Target intelligence / Profile preview

Glutathione S-transferase Mu 2 (GSTM2)

Target
GSTM2
Molecular classification
Enzyme, Phase II detoxification enzyme, Transferase (specifically glutathione S-transferase), Cytosolic enzyme
01

Overview

Glutathione S-transferase Mu 2 (GSTM2) is an enzyme of the mu class within the glutathione S-transferase superfamily, primarily found in the cytosol. It catalyzes the conjugation of reduced glutathione to a broad range of endogenous and exogenous hydrophobic electrophiles, thereby facilitating detoxification, scavenging reactive species, and protecting cells from oxidative stress. GSTM2 also plays specialized roles in lipid metabolism regulation and inhibits cell death signaling by binding to ASK1. The gene is highly polymorphic, which contributes to individual variability in susceptibility to carcinogens, drug toxicity, and metabolic diseases such as hepatic steatosis[1][2][4][6].

Other names
GSTM2Mu class GSTGlutathione S-transferase M2
02

Mechanism of action

Conjugation of reduced glutathione to hydrophobic electrophiles, increasing solubility and facilitating excretion; Protection from oxidative stress by scavenging reactive oxygen species; Inhibition of stress kinases (ASK1, JNK), impacting cell survival signaling

03

Biological functions

Detoxification of electrophilic compounds, including carcinogens, environmental toxins, and therapeutic drugsAntioxidant activity (scavenges reactive oxygen species)Regulates lipid metabolism and hepatic steatosisPeroxidase and isomerase activityNon-catalytic ligand binding (binds a range of endogenous/exogenous ligands)Modulates cell death signaling by inhibiting ASK1 and Jun N-terminal kinase
04

Disease associations

Cancer (modifies susceptibility to carcinogens)Liver disease/hepatic steatosisDrug toxicity and efficacyPossibly cardiovascular disease (inhibitory action on ryanodine receptor)
05

Safety considerations

Genetic polymorphisms in GSTM2 can affect individual drug response and risk for adverse drug reactions or toxin susceptibilityOver- or underexpression could interfere with drug metabolism or cellular antioxidant defense, leading to toxicity or increased disease risk.
06

Interacting drugs

Drugs whose metabolism involves glutathione conjugation (e.g., anticancer drugs such as cyclophosphamide, environmental toxins)
07

Biomarkers

GSTM2 polymorphisms are biomarkers for susceptibility to carcinogens, toxins, and responsiveness/toxicity to certain drugs

Beyond the preview

Go deeper on Glutathione S-transferase Mu 2 (GSTM2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glutathione S-transferase Mu 2 (GSTM2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call